Bank of New York Mellon Corp - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 24 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$60,000
-9.1%
45,1390.0%0.00%
Q2 2020$66,000
+57.1%
45,1390.0%0.00%
Q1 2020$42,000
+75.0%
45,139
+199.0%
0.00%
Q4 2019$24,000
-53.8%
15,0960.0%0.00%
Q3 2019$52,000
-7.1%
15,0960.0%0.00%
Q2 2019$56,000
-88.2%
15,096
-66.6%
0.00%
Q1 2019$474,000
+4.4%
45,157
+3.1%
0.00%
Q4 2018$454,000
-8.8%
43,789
+5.9%
0.00%
Q3 2018$498,000
+11.7%
41,359
+9.9%
0.00%
Q2 2018$446,00037,6320.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 785,950$9,314,0000.91%
Morse Asset Management, Inc 177,500$2,103,0000.58%
PARSONS CAPITAL MANAGEMENT INC/RI 281,213$3,332,0000.38%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 73,000$860,0000.33%
TIEDEMANN ADVISORS, LLC 412,049$4,883,0000.31%
Private Capital Advisors, Inc. 52,335$620,0000.19%
SECTORAL ASSET MANAGEMENT INC 131,656$1,560,0000.17%
Lee Financial Co 18,750$222,0000.05%
Baker Brothers Advisors 373,144$4,422,0000.03%
Alyeska Investment Group, L.P. 200,000$2,370,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders